William K. Fleming - 30 Sep 2024 Form 4 Insider Report for HUMANA INC (HUM)

Role: Chief Corporate Aff. Officer
Signature: William K. Fleming
Issuer symbol: HUM
Transactions as of: 30 Sep 2024
Transactions value $: $0
Form type: 4
Filing time: 30 Sep 2024, 12:01:10 UTC
Previous filing: 23 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	HUM	Humana Common						11.7K	30 Sep 2024	Direct	F11
holding	HUM	Humana Common						121	30 Sep 2024	See Footnote	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	HUM	Options						324	30 Sep 2024	Humana Common	324	$307.97	Direct	F2
holding	HUM	Options						2.15K	30 Sep 2024	Humana Common	2.15K	$350.79	Direct	F3
holding	HUM	Options						4.81K	30 Sep 2024	Humana Common	4.81K	$376.61	Direct	F4
holding	HUM	Options						3.75K	30 Sep 2024	Humana Common	3.75K	$425.06	Direct	F5
holding	HUM	Options						3.7K	30 Sep 2024	Humana Common	3.7K	$510.24	Direct	F6
holding	HUM	Options						5.39K	30 Sep 2024	Humana Common	5.39K	$367.21	Direct	F7
holding	HUM	Restricted Stock Units						345	30 Sep 2024	Humana Common	345		Direct	F8, F9
holding	HUM	Restricted Stock Units						639	30 Sep 2024	Humana Common	639		Direct	F8, F10
holding	HUM	Phantom Stock Units						24	30 Sep 2024	Humana Common	24		See Footnote	F12

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

William K. Fleming is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	Shares held for the benefit of reporting person as of August 31, 2024 under the Humana Retirement Savings Plan including routine payroll deductions, quarterly dividend allocation, and a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, exempt under Rule 16b-3(c).
F2	Right to buy pursuant to Company's 2011 Stock Incentive Plan. Non-Qualified stock options granted to reporting person on 02/25/2019, vesting in three increments from 2/25/20 to 2/25/22.
F3	Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23.
F4	Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24.
F5	Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25.
F6	Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26.
F7	Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.
F8	Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
F9	Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.
F10	Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.
F11	Includes 1,396 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.
F12	Phantom Stock Units held for the benefit of reporting person as of August 31, 2024 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.